Nuvation Bio Expands Access to Taletrectinib for Advanced ROS1-Positive NSCLC Patients in the U.S. Nuvation Bio a leading global biopharmaceutical company focused on developing innovative therapies for some of the most pressing unmet needs in oncology, has announced the initiation…
Galderma Leads in Aesthetic Injectables & Weight Loss Research New research reveals that loose or sagging skin on the face and neck is most commonly observed after medication-driven weight loss, with facial changes typically appearing 3-6 months post-treatment in 45%…
Enveric Biosciences Secures Patent Protection for Breakthrough Neuroplastogen EB-003 In a significant milestone for its innovative drug development pipeline, Enveric Biosciences (NASDAQ: ENVB) has announced the receipt of a Notice of Allowance (NOA) from the United States Patent and Trademark…
Ferrer Achieves Compliance Leader Verification™: A Testament to Excellence in Ethics and Corporate Responsibility In a significant milestone for ethical business practices, Ferrer, a global pharmaceutical company headquartered in Barcelona, has been awarded the prestigious Compliance Leader Verification™ by Ethisphere,…
RevBio Secures 10th Patent for TETRANITE®: Expanding Protection for Revolutionary Bone Adhesive Technology In a significant milestone for regenerative medicine, ITS, a clinical-stage medical device company, has been granted its 10th U.S. patent for its groundbreaking TETRANITE® bone adhesive technology.…
TNF Pharmaceuticals Launches Study Series to Preserve Lean Muscle Mass During GLP-1 Weight Loss Treatment TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory conditions, has announced the initiation of its…
Leveragen Inc. and Moonlight Bio Forge Strategic Collaboration to Revolutionize T Cell Therapies for Cancer Treatment Leveragen Inc., a pioneering biotech company based in Boston, has announced a groundbreaking partnership with Moonlight Bio, a Seattle-based biotech firm specializing in advanced…
Global Nanoemulsions Market Report 2024-2030: Growth Trends, Applications, and Forecasts Nanoemulsions – Global Strategic Business Report,” providing an in-depth analysis of the expanding nanoemulsions market. This report examines industry trends, market drivers, and forecasts, offering valuable insights for businesses and…
ENHERTU® Approved in U.S. for HER2-Low Metastatic Breast Cancer Post-Endocrine Therapy Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)…
Introduction: Cytokinetics Advances CK-586 into Phase 2 Trial Cytokinetics, Incorporated a leading biopharmaceutical company, has announced that enrollment is now open for AMBER-HFpEF, a pivotal Phase 2 clinical trial evaluating CK-586 in patients with symptomatic heart failure with preserved ejection…
Poxel Advances Global Strategy with Key Patent for Imeglimin in China Expanding Innovative Treatments for Chronic Metabolic Diseases Poxel, a clinical-stage biopharmaceutical company focused on developing cutting-edge treatments for chronic diseases with metabolic origins, has reached a significant milestone in…
WHO Welcomes Gaza Ceasefire but Highlights Immense Health Challenges Ahead The World Health Organization (WHO) has welcomed the Gaza ceasefire and the associated hostage and prisoner release deal, bringing a glimmer of hope to millions whose lives have been devastated…